B-D, 200X
Research Applications Tirzepatide has drawn considerable attention in preclinical and observational research for its potential effects on metabolic function, particularly in studies focused on obesity, insulin regulation, and energy expenditure
PMCID: PMC8275860
Potential Side Effects Retatrutide is generally well-tolerated but can cause temporary gastrointestinal symptoms such as nausea, bloating, or mild constipationespecially during the first few weeks or if dosage is increased too quickly
This fact paved the way for the development of a GIP receptor agonist-based therapy for T2DM, looking also for the possibility of finding a combined GLP-1/GIP receptor agonist
And there is another issue around such peptides: Importantly, information regarding the indications, dosing, frequency and duration of treatment remains unknown, the researchers wrote